DrugDevelopment | Financial Buzz

Breaking News Cannabis Buzz Healthcare Market News Products The Market Buzz

Breaking News: Mydecine Innovations Group Inc. Signs Partnership Agreement With Applied Pharmaceutical Innovation

financial buzz06/12/2020

10194

Mydecine Innovations Group Inc. (OTC: NLBIF) (CSE: MYCO), is pleased to announce the establishment of a research division agreement with Applied Pharmaceutical Innovation (“API”), a translational commercial drug development...

Breaking News Cannabis Buzz Market News The Market Buzz

Breaking News: NewLeaf Brands Appoints Former Director of Genetic Research of Ebbu, Lead Director of Genetic Research of Canopy Growth & Recent Co-founder of Mydecine Group, Rob Roscow, to the Role of Chief Science Officer

financial buzz05/12/2020

3594

NewLeaf Brands Inc. (OTC: NLBIF) (CSE: NLB) is pleased to announce that it has appointed Robert Roscow to the position of Chief Science Officer (CSO). Mr. Roscow previously served...

Biotechnology Breaking News Buzz On The Street Market News Technology The Buzz TV The Market Buzz Top Videos Video

“Buzz on the Street” Show: NanoViricides, Inc. (NYSE: NNVC) Coronavirus Drug Development Update

financial buzz03/16/2020

4263

FinancialBuzz.com’s latest Buzz on the Street Show: Featuring Our Corporate News Recap on “Coronavirus Drug Development Update from NanoViricides, Inc.” NanoViricides, Inc. (NYSE: NNVC) (the “Company”) a leader in...

Biotechnology Breaking News Market News Technology The Market Buzz

Breaking News: Coronavirus Drug Development Update from NanoViricides, Inc.

financial buzz03/16/202003/24/2020

2977

NanoViricides, Inc. (NYSE: NNVC) (the “Company”) a leader in the development of highly effective antiviral therapies based on a novel nanomedicines platform (the “Company”), is providing an update on...

Biotechnology Breaking News Market News Technology The Market Buzz

Breaking News: NanoViricides Confirms It Has Been Working On A Treatment For The Novel Wuhan Coronavirus

financial buzz01/31/202002/11/2020

9411

NanoViricides, Inc. (NYSE: NNVC) a global leader in the development of highly effective antiviral therapies based on a novel nanomedicines platform, is confirming public disclosures in articles by various...

Biotechnology Breaking News Buzz On The Street Healthcare Market News Technology The Buzz TV The Market Buzz Top Videos Video

“Buzz on the Street” Show: Q BioMed Inc. (OTCQB: QBIO) Announces FDA Approval

financial buzz11/20/201911/26/2019

9464

2

FinancialBuzz.com’s latest Buzz on the Street Show: Featuring Our Corporate News Recap on “Q BioMed Announces FDA Approval.” Q BioMed Inc. (OTCQB: QBIO), announces FDA approval of its contract manufacturer...

Biotechnology Breaking News Market News Technology The Market Buzz

Breaking News: Oncology Pharma and Ribera Solutions Signed a Licensing Agreement for the Use of Ribera’s Clinical Trials Platform, Connect2Med

financial buzz11/06/201911/18/2019

5052

1

Oncology Pharma Inc. (OTC: ONPH) is pleased to announce that it has entered into an agreement with Ribera for its clinical trial platform, “Connect2Med”. The license by Ribera of...

Biotechnology Breaking News Buzz On The Street Market News Technology The Buzz TV The Market Buzz Top Videos Video

“Buzz on the Street” Show: Q BioMed Inc. (OTCQB: QBIO) Partner Mannin Announces USD 7.5M Grant

financial buzz11/05/201904/29/2020

4775

1

FinancialBuzz.com’s latest Buzz on the Street Show: Featuring Our Corporate News Recap on “Q BioMed Announces $7.5M Grant Benefiting its Preclinical Product Development Pipeline.” Q BioMed Inc. (OTCQB: QBIO), a commercial...

Biotechnology Investing News Market News Technology

Biogen Rises over 35% on Plans to Pursue FDA Approval

Bryan Shin10/22/2019

3683

3

Biogen Inc. (NASDAQ: BIIB) shares surged by over 35% on Tuesday morning after the Company announced it will seek U.S. FDA approval for its Alzheimer’s drug, aducanumab. Aducanumab is...

Breaking News Cannabis Buzz Market News The Market Buzz

Breaking News: Pasha Brands Appoints Dr. Brigitte Simons as Chief Scientific Officer to High Value Craft Cannabis Organization

financial buzz06/11/201906/17/2019

4632

1

Pasha Brands Ltd. (CSE: CRFT), Canada’s largest organization of craft cannabis brands, is pleased to announce the appointment of Dr. Brigitte Simons as its new Chief Scientific Officer. Dr. Simons will bring extensive...

Tag: DrugDevelopment

Breaking News: Mydecine Innovations Group Inc. Signs Partnership Agreement With Applied Pharmaceutical Innovation

Breaking News: NewLeaf Brands Appoints Former Director of Genetic Research of Ebbu, Lead Director of Genetic Research of Canopy Growth & Recent Co-founder of Mydecine Group, Rob Roscow, to the Role of Chief Science Officer

“Buzz on the Street” Show: NanoViricides, Inc. (NYSE: NNVC) Coronavirus Drug Development Update

Breaking News: Coronavirus Drug Development Update from NanoViricides, Inc.

Breaking News: NanoViricides Confirms It Has Been Working On A Treatment For The Novel Wuhan Coronavirus

“Buzz on the Street” Show: Q BioMed Inc. (OTCQB: QBIO) Announces FDA Approval

Breaking News: Oncology Pharma and Ribera Solutions Signed a Licensing Agreement for the Use of Ribera’s Clinical Trials Platform, Connect2Med

“Buzz on the Street” Show: Q BioMed Inc. (OTCQB: QBIO) Partner Mannin Announces USD 7.5M Grant

Biogen Rises over 35% on Plans to Pursue FDA Approval

Breaking News: Pasha Brands Appoints Dr. Brigitte Simons as Chief Scientific Officer to High Value Craft Cannabis Organization

About Us

Instagram

Latest Tweets